| 证候类中药新药临床试验的证候诊断路径思考 |
| |
| 引用本文： | 高颖,吴圣贤,王少卿,王忠,王永炎. 证候类中药新药临床试验的证候诊断路径思考[J]. 中西医结合心脑血管病杂志, 2014, 0(8): 1010-1012 |
| |
| 作者姓名： | 高颖 吴圣贤 王少卿 王忠 王永炎 |
| |
| 作者单位： | 北京中医药大学东直门医院教育部中医内科学重点实验室,100700 |
| |
| 基金项目： | 十二五重大新药创制项目：中药新药临床评价研究技术平台建设（No.2011ZX09302-006-01） |
| |
| 摘 要： | 证候类新药开发是符合中医药特色的、具有独立创新性的新药研发模式,而证候的选择与诊断是其研究的难点之一。本文围绕证候的确立、证候与疾病的关系、证候的诊断等等问题进行探讨,希望能对证候类中药的诊断模式提供些许参考。
|
| 关 键 词： | 证候 中药 临床试验 诊断路径 |
Thinking on Chinese Medicine Diagnosis Model in Clinical Trials of Syndrome Class New Drug |
| |
| Affiliation: | Gao Ying, Wu Shengxian, Wang Shaoqing, et al(Dongzhimen Hospital,Beijing University of Chinese Medicine(Beijing 100700)) |
| |
| Abstract: | Objective The development of syndrome class new drug is conform to the characteristics of the traditional Chinese medicine.It is an independent and innovative new drug research mode,and the choice of syndromes and diagnosis are the most difficult points of the research.This paper focus on the establishment of syndrome,syndrome and disease and the relations between syndrome diagnosis and so on,and hope to provide some reference for the Chinese medicine diagnosis model. |
| |
| Keywords: | syndrome Chinese drug clinical trials diagnosis model |
| 本文献已被 维普 等数据库收录！ |
|
